Frontiers “Brain Fog” by COVID-19 or Alzheimer's Disease? A Case

Cognitive symptoms after COVID-19 have been increasingly recognized several months after the acute infection and have been designated as “brain fog.” We repo

Citicoline and COVID-19: vis-à-vis conjectured Naunyn-Schmiedeberg's Archives of Pharmacology

Frontiers Case report: Assessment of linguistic, cognitive, and sensory profile competencies in a child with ASD and epilepsy

PDF) Investigation of Cognitive Impairment in the Course of Post-COVID Syndrome

Are COVID-19 “Brain Fog” Symptoms and an Auditory Processing Disorder Related?

blood-brain barrier – NIH Director's Blog

Frontiers Mitigating Long-Term COVID-19 Consequences on Brain Health

Neuropsychological assesment - List of Frontiers' open access articles

Blood-brain barrier breakdown in COVID-19 ICU survivors: an MRI pilot study

PDF) Neuropsychological, plasma marker, and functional connectivity changes in Alzheimer's disease patients infected with COVID-19

Probing the Neuro-psychological Changes Observed with the Administration of COVID-19 Drugs

A pilot study to assess blood-brain barrier permeability in long COVID

Frontiers Addressing the Interactive Effects of Maltreatment and COVID-19 Related Stressors on the Neuropsychological Functioning in Children

Fluid biomarkers - List of Frontiers' open access articles

Descriptive and Narrative Study of Long Covid Cases in General Practice and Diagnostic Value of Single Photon Emission Computed Tomography (SPECT scan)